[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336230-105":59,"doc-detail-336230-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","evolving-tumor-characteristics-and-smart-nanodrugs-for-tumor-immunotherapy-review","Evolving Tumor Characteristics and Smart Nanodrugs for Tumor Immunotherapy - Review","","Typical tumor physiological features—weak acidity, low oxygen content, and increased enzyme activity in the tumor microenvironment (TME)—can give tumors survival benefits under targeted drug and responsive nanomedicine attacks. Treatment progress has been rapid, yet tumor evolution and adaptation still obstruct current strategies. Effective and precise therapy requires understanding how cancer-cell heterogeneity changes during evolution, leveraging TME traits while controlling mutational processes.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/evolving-tumor-characteristics-and-smart-nanodrugs-for-tumor-immunotherapy-review/336230/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/evolving-tumor-characteristics-and-smart-nanodrugs-for-tumor-immunotherapy-review/336230.png","ImageObject",300,407,{"name":92,"@type":93},"Emma Wilson","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-02","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What tumor microenvironment features help tumors survive targeted treatments?","Question",{"text":112,"@type":113},"Tumors exploit weak acidity, low oxygen, and upregulated enzymes in the TME, which can provide survival advantages when exposed to targeted drugs and responsive nanomedicines.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Why do tumor evolution and adaptation remain challenging for cancer therapy?",{"text":117,"@type":113},"Tumor characteristics evolve and adapt over time, undermining current treatment effectiveness even as therapies progress.",{"name":119,"@type":110,"acceptedAnswer":120},"How do TME-responsive nanomedicines improve cancer treatment?",{"text":121,"@type":113},"They offer enhanced selectivity, permeability, and controlled drug release by targeting either tumor-cell-specific markers or unique physiological/pathological properties of tumor tissues such as acidic pH, high osmotic pressure, and altered redox state.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336230,1790618022,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":26,"preview_page_count":19,"preview_urls":145},3848291630094,"https://eur-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","International Journal of Nanomedicine Dovepress  \nopen access to scientific and medical research  \n Open Access Full Text Article REVIEW  \nEvolving Tumor Characteristics and Smart Nanodrugs for Tumor Immunotherapy  \nWenshe Sun 1–3 , *, Shaowei Xie 4 , *, Shi Feng Liu 1 , *, Xiaokun Hu 1 , Dongming Xing 1 , 2  \n1The Affiliated Hospital of Qingdao University, Qingdao, 266071, People’s Republic of China; 2Qingdao Cancer Institute, Qingdao University, Qingdao, 266071, People’s Republic of China; 3Medical Science and Technology Innovation Center, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, 250117, People’s Republic of China; 4Department of Ultrasound, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, People’s Republic of China  \n*These authors contributed equally to this work  \nCorrespondence: Xiaokun Hu; Dongming Xing, The Affiliated Hospital of Qingdao University, Qingdao, 266071, People’s Republic of China,  \nEmail [huxiaokun770@163.com](huxiaokun770@163.com); [xdm_tsinghua@163.com](xdm_tsinghua@163.com)  \n\n| Abstract: Typical physiological characteristics of tumors, such as weak acidity, low oxygen content, and upregulation of certain enzymes in the tumor microenvironment (TME), provide survival advantages when exposed to targeted attacks by drugs and responsive nanomedicines. Consequently, cancer treatment has significantly progressed in recent years. However, the evolution and adaptation of tumor characteristics still pose many challenges for current treatment methods. Therefore, efficient and precise cancer treatments require an understanding of the heterogeneity degree of various factors in cancer cells during tumor evolution to exploit the typical TME characteristics and manage the mutation process. The highly heterogeneous tumor and infiltrating stromal cells, immune cells, and extracellular components collectively form a unique TME, which plays a crucial role in tumor malignancy, including proliferation, invasion, metastasis, and immune escape. Therefore, the development of new treatment methods that can adapt to the evolutionary characteristics of tumors has become an intense focus in current cancer treatment research. This paper explores the latest understanding of cancer evolution, focusing on how tumors use new antigens to shape their “new faces”; how immune system cells, such as cytotoxic T cells, regulatory T cells, macrophages, and natural killer cells, help tumors become “invisible”, that is, immune escape; whether the diverse cancer-associated fibroblasts provide support and coordination for tumors; and whether it is possible to attack tumors in reverse. This paper discusses the limitations of targeted therapy driven by tumor evolution factors and explores future strategies and the potential of intelligent nanomedicines, including the systematic coordination of tumor evolution factors and adaptive methods, to meet this therapeutic challenge.\u003Cbr>Keywords: smart nanomedicine, tumor evolution, immune cells, fibroblasts |\n| --- |\n| Introduction\u003Cbr>Cancer development is driven by an environment that fosters cellular evolution and genetic instability.1 Key factors contributing to this instability include acidosis, hypoxia, and the presence of reactive oxygen species, which are highly selective forces that induce genetic mutations.2 Therefore, malignant cancers have emerged as dynamic evolutionary entities composed of cells adapted to survive in various microhabitats. This adaptation helps prevent the onset of drug resistance. Cytotoxic cancer therapies, such as radiotherapy, exert significant evolutionary pressure on surviving cells, accelerating their rate of mutation and evolution. Nanomedicines designed to target specific components of the tumor microenvironment (TME) have shown promise owing to their enhanced selectivity, permeability, and drug-release capabilities. These properties enable effective targeting of the TME, thereby improving th","cbCair6hgAmqO9lz","https://ap.wps.com/l/cbCair6hgAmqO9lz","pdf",6634943,24,"English","# Introduction\n## Tumor evolution drivers and genetic instability\n## TME-responsive nanomedicines and targeting modes\n## pH-, temperature-, and enzyme-responsive strategies","[{\"question\":\"What tumor microenvironment features help tumors survive targeted treatments?\",\"answer\":\"Tumors exploit weak acidity, low oxygen, and upregulated enzymes in the TME, which can provide survival advantages when exposed to targeted drugs and responsive nanomedicines.\"},{\"question\":\"Why do tumor evolution and adaptation remain challenging for cancer therapy?\",\"answer\":\"Tumor characteristics evolve and adapt over time, undermining current treatment effectiveness even as therapies progress.\"},{\"question\":\"How do TME-responsive nanomedicines improve cancer treatment?\",\"answer\":\"They offer enhanced selectivity, permeability, and controlled drug release by targeting either tumor-cell-specific markers or unique physiological/pathological properties of tumor tissues such as acidic pH, high osmotic pressure, and altered redox state.\"}]","Evolving Tumor Characteristics and Smart Nanodrugs for Tumor Immunotherapy - Review | PDF",1790014206,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c79ca30f03c68d02fb44a1031df36362.webp",983,1272,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9894fd3d3b758ee30f062a08d9407715.webp",982,1270,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a74580db79709b35be70983f1cd33539.webp",981,1269,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bba1b316b8b8699d294385c4975dc6dd.webp",980,1268]